IGF-1 diurnal AM
Selected indexed studies
- Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4. (Eur J Endocrinol, 2025) [PMID:40400262]
- Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. (J Am Coll Cardiol, 2001) [PMID:11451284]
- Pulsatile nature of growth hormone levels in critically ill trauma victims. (Surgery, 1995) [PMID:7716722]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pulsatile nature of growth hormone levels in critically ill trauma victims. (1995) pubmed
- Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4. (2025) pubmed
- Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. (2001) pubmed
- Regulation of insulin-like growth factor binding protein-1 during the 24-hour metabolic clock and in response to hypoinsulinemia induced by fasting and Sandostatin in normal women. (1995) pubmed
- Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. (1997) pubmed
- Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome. (2012) pubmed
- Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. (2001) pubmed
- Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson's disease. (2013) pubmed
- Criteria for recognition of the growth-inefficient child who may respond to treatment with growth hormone. (1989) pubmed
- Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women. (2005) pubmed